Skip to content
OpenCapital
Get started

PROCEPT BioRobotics Corporation PRCT Stock-Based Comp

Stock-Based Comp at other companies

TFX
TeleflexTFX
$6.74M+1.7%
Boston Scientific logo
Boston ScientificBSX
$83M+12.2%
Intuitive Surgical logo
Intuitive SurgicalISRG
$209.5M+13.1%
Absci Corporation logo
Absci CorporationABSI
$4.38M-10.8%
Envista Holdings Corporation logo
Envista Holdings CorporationNVST
$10.2M+43.7%
iRadimed logo
iRadimedIRMD
$684K-17.2%

Other financials

Income statement

See full
Revenue$83.1M+20.2%
Gross profit$53.9M+22.2%
Operating income-$32.6M-18.8%
Net income-$31.6M-27.9%
EPS (diluted)-$0.56-24.4%

Balance sheet

See full
Cash & equivalents$12.2M-96.2%
Total debt$78.0M-11.8%
Total equity$347.7M-10.7%
Total assets$487.1M-6.2%

Cash flow

See full
Operating cash flow-$38.1M-125%
CapEx$2.9M+58.7%
Free cash flow-$41.0M-118%

Valuation

See full
Market cap$1.19B-22.5%
Enterprise value$1.25B—
P/S3.7×—

Profitability

See full
Gross margin64%+1.3pp
Operating margin-33.9%-3.8pp
Net margin-31.8%-3.4pp
FCF margin-25%-5.7pp

Returns & leverage

See full
Return on equity-27.8%+0.2pp
Debt / equity0.2×0.0×
Current ratio6.7×-2.2×

Where this comes from

Reported directly by PROCEPT BioRobotics Corporation in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: PROCEPT BioRobotics Corporation’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about PROCEPT BioRobotics Corporation's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PROCEPT BioRobotics Corporation's stock-based comp?
PROCEPT BioRobotics Corporation (PRCT) reported stock-based comp of $13.07M in Q1 2026.
How has PROCEPT BioRobotics Corporation's stock-based comp changed year-over-year?
PROCEPT BioRobotics Corporation's stock-based comp increased by 29.3% year-over-year, from $10.11M to $13.07M.
What is the long-term trend for PROCEPT BioRobotics Corporation's stock-based comp?
Over 4 years (2021 to 2025), PROCEPT BioRobotics Corporation's stock-based comp has grown at a 88.2% compound annual growth rate (CAGR), from $3.8M to $47.6M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.